Beneficiaries with a BMI of 35 or higher qualify without additional clinical requirements, while those with a BMI of 30 or higher must also have chronic kidney disease at stage 3a or above, heart failure with preserved ejection fraction, or uncontrolled hypertension despite treatment with two medications
The side effects are real annoying at best and debilitating at worst and can include nausea, diarrhea, cramps and abdominal pain, constipation, vomiting, gastroesophageal reflux, gastroenteritis, pancreatitis, gastroparesis, intestinal obstruction, gall bladder disease, headaches and potential risk for certain types of thyroid and endocrine cancers, among other adverse effects
Can GLP-1 medications affect my relationship with food
GLP-1 weight loss drugs didnt create health inequities but Medicaid cuts may deepen them
weight loss on tirzepatide and semaglutide (Mounjaro and Wegovy) reports a new right axillary lump
Have smaller portions